Curia Global, Inc.
There’s no substitute for experience. Curia is an end-to-end CDMO built to help pharmaceutical and biotech companies improve patients’ lives. We combine a flexible suite of R&D and manufacturing capabilities with industry-leading expertise to help our partners accelerate the journey from idea to impact.
We’ve come a long way from our founding in 1991 as Albany Molecular Research, Inc. (AMRI). Originally known for the discovery and development of the active pharmaceutical ingredient (API) in Allegra, we’ve built a strong foundation over the past three decades. Now known as Curia, we’re always evolving to add a wide array of new capabilities and developing a comprehensive suite of solutions capable of serving customers across the drug development spectrum.
President, Research and Development